{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:18:29Z","timestamp":1793114309709,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic immune activation persists in persons living with HIV-1 even though they are aviremic under antiretroviral therapy, and fuels comorbidities. In previous studies, we have revealed that virologic responders present distinct profiles of immune activation, and that one of these profiles is related to microbial translocation. In the present work, we tested in 140 HIV-1-infected adults under efficient treatment for a mean duration of eight years whether low-level viremia might be another cause of immune activation. We observed that the frequency of viremia between 1 and 20 HIV-1 RNA copies\/mL (39.5 \u00b1 24.7% versus 21.1 \u00b1 22.5%, p = 0.033) and transient viremia above 20 HIV-1 RNA copies\/mL (15.1 \u00b1 16.9% versus 3.3 \u00b1 7.2%, p = 0.005) over the 2 last years was higher in patients with one profile of immune activation, Profile E, than in the other patients. Profile E, which is different from the profile related to microbial translocation with frequent CD38+ CD8+ T cells, is characterized by a high level of CD4+ T cell (cell surface expression of CD38), monocyte (plasma concentration of soluble CD14), and endothelium (plasma concentration of soluble Endothelial Protein C Receptor) activation, whereas the other profiles presented low CD4:CD8 ratio, elevated proportions of central memory CD8+ T cells or HLA-DR+ CD4+ T cells, respectively. Our data reinforce the hypothesis that various etiological factors shape the form of the immune activation in virologic responders, resulting in specific profiles. Given the type of immune activation of Profile E, a potential causal link between low-level viremia and atherosclerosis should be investigated.<\/jats:p>","DOI":"10.3389\/fimmu.2021.663843","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:39:43Z","timestamp":1617064783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Mehwish","family":"Younas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Psomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Cezar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Kundura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Portal\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Atoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Le Moing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Barbuat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Corbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e95061","DOI":"10.1371\/journal.pone.0095061","article-title":"Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy","volume":"9","author":"Miller","year":"2014","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e000844","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"Nordell","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12013","article-title":"Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals","volume":"14","author":"Longenecker","year":"2013","journal-title":"HIV Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506857102","article-title":"Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy","volume":"102","author":"Popovic","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17215","DOI":"10.1038\/s41598-018-35478-1","article-title":"HIV-1 Envelope Glycoproteins Induce the Production of TNF-\u03b1 and IL-10 in Human Monocytes by Activating Calcium Pathway","volume":"8","author":"Plan\u00e8s","year":"2018","journal-title":"Sci Rep Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.4.753-777.2001","article-title":"Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection","volume":"14","author":"Lawn","year":"2001","journal-title":"Clin Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9747","DOI":"10.1038\/s41598-018-28114-5","article-title":"Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation","volume":"8","author":"Yakovian","year":"2018","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/hiv.12310","article-title":"Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy","volume":"17","author":"Younas","year":"2016","journal-title":"HIV Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pbio.0040365","article-title":"Human immunodeficiency virus impairs reverse cholesterol transport from macrophages","volume":"4","author":"Mujawar","year":"2006","journal-title":"PLoS Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-017-2676-2","article-title":"Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns","volume":"17","author":"Falasca","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"213","author":"Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000815","article-title":"Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia","volume":"30","author":"Guihot","year":"2016","journal-title":"AIDS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1006285","DOI":"10.1371\/journal.ppat.1006285","article-title":"Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation","volume":"13","author":"Gandhi","year":"2011","journal-title":"PLoS Pathog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir208","article-title":"Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy","volume":"204","author":"Chun","year":"2011","journal-title":"J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23679","article-title":"Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"85","author":"Allavena","year":"2013","journal-title":"J Med Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw650","article-title":"Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression","volume":"63","author":"Castillo-Mancilla","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001629","article-title":"Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression","volume":"77","author":"Castillo-Mancilla","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0173893","DOI":"10.1371\/journal.pone.0173893","article-title":"Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers","volume":"12","author":"Chereau","year":"2017","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1003691","DOI":"10.1371\/journal.ppat.1003691","article-title":"Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers","volume":"9","author":"Hatano","year":"2013","journal-title":"PLoS Pathog"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-018-1046-2","article-title":"Switching to dual\/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study","volume":"16","author":"Mussini","year":"2018","journal-title":"BMC Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3198-2","article-title":"Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015","volume":"285","author":"Quiros-Roldan","year":"2018","journal-title":"BMC Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/hiv.12716","article-title":"Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch","volume":"20","author":"Moreno","year":"2019","journal-title":"HIV Med"},{"key":"B25","article-title":"Day-On, Day-Off emtricitabine, tenofovir disoproxil fumarate and efavirenz single tablet regimen (DODO) as maintenance therapy in HIV-infected patients","volume":"26","author":"Costantini","year":"2018","journal-title":"Infez Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx434","article-title":"Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial","volume":"73","author":"de Truchis","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02185","article-title":"Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia","volume":"10","author":"Younas","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.05.008","article-title":"One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study","volume":"8","author":"Psomas","year":"2016","journal-title":"EBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182745ab0","article-title":"Low-level HIV viremia is associated with microbial translocation and inflammation","volume":"62","author":"Reus","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000134298.25489.92","article-title":"Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation","volume":"24","author":"Van de Wouwer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e37032","DOI":"10.1371\/journal.pone.0037032","article-title":"Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients","volume":"7","author":"Nozza","year":"2012","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw010","article-title":"Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART","volume":"71","author":"Chiappetta","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.12.007","article-title":"Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus","volume":"210","author":"Reynolds","year":"2010","journal-title":"Atherosclerosis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0215507","DOI":"10.1371\/journal.pone.0215507","article-title":"Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015","volume":"14","author":"Masi\u00e1","year":"2019","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cca.2015.05.003","article-title":"Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study","volume":"447","author":"Engelberger","year":"2015","journal-title":"Clin Chim Acta"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.663843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:39:47Z","timestamp":1617064787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.663843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2021.663843"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.663843","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"article-number":"663843"}}